Elise Needham PhD GAICD

Experience

• 

  Ormond College

  Jan 1999 - Jan 2004

  Resident Tutor

  • Tutored physiology and chemistry in classes for science, engineering, physiotherapy and dental students.• Elected to the College Council with participation in monthly board meetings.

• 

  University of Melbourne

  Jan 2000 - Jan 2005

  Medical Tutor

  • Tutored groups of first to third year medical students with case-based learning, individual feedback and coaching, and exam assessments.

• 

  Royal Australian and New Zealand College of Psychiatrists

  Jan 2004 - Jan 2006

  Research Projects Manager

  * Developed and implemented strategies to promote evidence-based treatmentrecommendations in Australian and New Zealand health services.* Managed multiple stakeholders to develop a novel online orientation program to assistoverseas trained doctors integrating into the Australian healthcare system.* Actively represented the College in government and external group meetings during the development of these projects.• Regular interaction with scientific leaders, health care networks, public health committees and related organisations. Show less

• 

  Royal Melbourne Hospital

  Jan 2004 - Jan 2006

  Clinical Trial Coordinator

  • Site coordinator from initiation to close-out for an international phase 3b clinical trial.• This included patient screening, regular communication with the study investigators and pharmaceutical sponsor, and oversight of site study finances.

• 

  Baker Heart and Diabetes Institute

  Jan 2006 - Jan 2011

  Business Development & Contracts

  * Led the licensing/partnering process by screening, identifying and analysing newopportunities and partners to evaluate their business potential.* Established relationships with potential licensing partners and external stakeholders.* Oversaw commercial terms and contract negotiation, having developed valuation andfinancial skills, to formulate agreements with various health organisations for the Institute’spre-clinical and clinical development of tangible and intangible IP assets, with over $2million income per year. Show less

• 

  Bristol-Myers Squibb Australia

  Jan 2011 - Jan 2013

  National Scientific Advisor - Immunology

  • Medical science management position for a marketed innovator biotherapeutic that was undergoing rapid uptake and revenue growth to later become a blockbuster (multi billion US$ sales) in the rheumatology portfolio.• Scientific exchange with therapeutic area thought leaders and organised medical education events with international speakers.• Responsible for internal strategic advice and document approval.• Also involved in pipeline activities for new biologic treatments for auto-immune disorders. Show less

• 

  Boehringer Ingelheim

  Jan 2014 - Jan 2016

  Senior Global Biopharmaceuticals Third Party Management

  • Working in the Global Biopharmaceuticals Strategy & Competitive Supply group to lead large international outsourcing projects for biologics development.• Led cross-functional teams to screen and assess proposals, then conducted due diligenceto select global businesses for high-quality strategic partnerships for biopharmaceuticaldevelopment. Each project had a budget of over 9 million EUR and multiple projects ran in parallel. • Led negotiation of agreements and oversaw third parties from project initiation to close-out. Show less

• 

  Boehringer Ingelheim

  Sept 2016 - Jun 2022

  Biopharmaceuticals, Global Product Operations

  • Responsible for commercial strategy and international production partnerships, for interdisciplinary teams to reliably produce medications to treat acute ischaemic stroke and myocardial infarction, withannual sales exceeding US$1 billion.• Championed business case to invest over 50 million EUR to transfer operations to a new manufacturing site to ensure future supply continuity.• Key role with contracts strategy, including product license and supply agreements, while ensuringcontractual obligations were met.• Involved with a high profile immunology clinical project to guide its development towards meeting commercial objectives and requirements. Show less

• 

  Stealth Startup

  Jun 2022 - Nov 2023

  Founder

  New approach in the health sciences sector for evidence-based prevention and reduction of cardiometabolic diseases.Supported by Antler VC, Blackbird Giants, Monash Generator and others.

• 

  University of Melbourne

  Nov 2023 - Oct 2024

  Genesis Ventures

  The Genesis Ventures Pre-Seed Fund is established in partnership with the government's Breakthrough Victoria fund, and provides financial investment, expertise, networks and mentoring for startup companies in deep tech fields of innovation.As Venture Creator, provided life sciences new ventures advice, and established connections with academic experts and industry key stakeholders to advance technologies via startup company investments.Identified, evaluated and developed high potential startups from the University’s R&D ecosystem, including delivering detailed business proposals for investment consideration. Show less

• 

  BioCurate Pty Ltd

  Sept 2024 - Dec 2024

  Consultant
• 

  MTPConnect

  Nov 2024 - now

  Senior Therapeutics Commercialisation Specialist

  Seconded to CSL for Australia's Targeted Translation Research Accelerator (TTRA) program. This instalment of the TTRA program is to fund and support the development of new therapeutics to treat cardiovascular diseases and diabetes complications.